7th NF-kB
International
Congress
Barcelona, October 7 to 9, 2026
Dear Friends and Colleagues,
Following the success of previous editions, the 7th International NF-kB Congress is set to bring together leading researchers from Europe and around the world. This year, the meeting will feature dedicated sessions exploring the central roles of NF-kB subunits and their key regulators in major biological processes, particularly those linked to stemness, cancer, and development.
So, welcome to the 7th NF-kB International Congress that will be held in Barcelona from
October 7 to 9, 2026.
About the Venue
The Barcelona Biomedical Research Park (PRBB) is one of the largest biomedical research hubs in southern Europe. Located next to the sea in the Barceloneta district of Barcelona, the PRBB brings together a community of over 1,400 researchers, students, and support staff working across multiple disciplines in life sciences and biomedicine.
Inaugurated in 2006, the PRBB is more than just a building—it is a scientific ecosystem designed to foster collaboration, innovation, and excellence in research. It houses several leading research centers, including the Centre for Genomic Regulation (CRG), the Hospital del Mar Research Institute (IMIM), the Barcelona Institute for Global Health (ISGlobal), the Department of Medicine and Life Sciences of Pompeu Fabra University (UPF), the Centre for Research in Environmental Epidemiology (CREAL), and the European Molecular Biology Laboratory – Barcelona site (EMBL Barcelona), among others.
Research at the PRBB spans a broad range of topics, from genetics and cell biology to public health, epidemiology, and computational biology. This multidisciplinary environment encourages synergy between basic and clinical research, aiming to translate scientific discoveries into tangible benefits for human health.
The park also emphasizes training, outreach, and ethical research practices. It hosts graduate and postgraduate programs in collaboration with UPF and other academic institutions, and it actively engages with the public through events, open days, and science communication initiatives.
As a model of co-location and interdisciplinary cooperation, the PRBB has positioned itself as a key player in the European research landscape. Its unique architecture, open science philosophy, and commitment to cutting-edge research make it a vibrant center for scientific advancement and innovation.
The Barcelona Biomedical Research Park (PRBB) is one of the largest biomedical research hubs in southern Europe. Located next to the sea in the Barceloneta district of Barcelona, the PRBB brings together a community of over 1,400 researchers, students, and support staff working across multiple disciplines in life sciences and biomedicine.
Inaugurated in 2006, the PRBB is more than just a building—it is a scientific ecosystem designed to foster collaboration, innovation, and excellence in research. It houses several leading research centers, including the Centre for Genomic Regulation (CRG), the Hospital del Mar Research Institute (HMRIB), the Barcelona Institute for Global Health (ISGlobal), the Department of Medicine and Life Sciences of Pompeu Fabra University (UPF), the Centre for Research in Environmental Epidemiology (CREAL), and the European Molecular Biology Laboratory – Barcelona site (EMBL Barcelona), among others.
Research at the PRBB spans a broad range of topics, from genetics and cell biology to public health, epidemiology, and computational biology. This multidisciplinary environment encourages synergy between basic and clinical research, aiming to translate scientific discoveries into tangible benefits for human health.
The park also emphasizes training, outreach, and ethical research practices. It hosts graduate and postgraduate programs in collaboration with UPF and other academic institutions, and it actively engages with the public through events, open days, and science communication initiatives.
As a model of co-location and interdisciplinary cooperation, the PRBB has positioned itself as a key player in the European research landscape. Its unique architecture, open science philosophy, and commitment to cutting-edge research make it a vibrant center for scientific advancement and innovation.
Program
Wednesday, October 7th
SESSION II: NF-κB IN INFLAMMATION AND IMMUNITY Chairs: Claus Scheidereit and Raquel Espín-Palazón
Thursday, October 8th
Chairs: Anna Bigas and Manolis Pasparakis
Friday, October 9th
Scientific committee
Veronique Baud
Université Paris Cité, Paris
Ruaidhri Carmody
University of Glasgow, UK
Nuno Dos Santos
University of Porto, Portugal
Raquel Espin-Palazon
Iowa State University, USA
Lluís Espinosa
Hospital del Mar Research Institute, Spain
Alexander Hoffmann
University of California Los Angeles, USA
Daniel Krappmann
Molecular Targets and Therapeutics Center (MTTC), Helmholtz Munich, Germany
Neil Perkins
Newcastle University, UK
Sonia Rocha
University of Liverpool, UK
Lienhard Schmitz
University Giessen, Germany
Laura Solé
Hospital del Mar Research Institute, Spain
Speakers
Daniel Álvarez
University of Miami
Veronique Baud
Université Paris Cité, France
Rudi Beyaert
Ghent University, Belgium
Anna Bigas
Josep Carreras Leukaemia Research Institute, Spain
Markus Bredel
University of Miami, USA
Ruaidhri Carmody
University of Glasgow, UK
Matthew Cook
University of Cambridge, UK
Emmanuel Dejardin
University of Liège, GIGA-Institute, Belgium
Nuno Dos Santos
University of Porto, Portugal
Raquel Espin-Palazon
Iowa State University, USA
Guido Franzoso
Imperial College London, UK
Gourisankar Ghosh
UC San Diego, USA
Bodo Grimbacher
University of Freiburg, Germany
Alexander Hoffmann
University of California Los Angeles, USA
Tom Huxford
San Diego State University, California, USA
Michael Kracht
Justus-Liebig-University Giessen, Germany
Daniel Krappmann
Molecular Targets and Therapeutics Center (MTTC), Helmholtz Munich, Germany
Simon MacKay
Strathclyde University, UK
Alexis Maillard
Imagine Institute/University of Paris, France
Simon Mitchell
Brighton and Sussex Medical School, UK
Michael Naumann
Otto von Guericke University, Germany
Manolis Pasparakis
University of Cologne, Germany
Neil Perkins
Newcastle University, UK
Sonia Rocha
University of Liverpool, UK
Ranjan Sen
Biomedical Research Center, NIH, National Institute on Aging, USA
Lienhard Schmitz
University Giessen, Germany
Lesley Stark
University of Edinburgh, UK
Myong-Hee Sung
National Institute of Aging, NIH, USA
Henning Walczak
University of Cologne, Germany. University College London, UK
Vivien Wang
University of Macau, China
Jana Wolf
Max Delbrück Center, Germany
The report
The 7th NF-κBInternational Congress, held from 7 to 9 October 2026 at the Barcelona Biomedical Research Park (PRBB), brought together 107 participants, with nearly equal representation of men and women. The meeting attracted a broad international audience, primarily from Germany and the United Kingdom, followed by the United States and Spain.
The scientific program showcased advances in our understanding of NF-κB and its regulators in gene regulation, inflammation, immunity, development, and cell differentiation. Several presentations highlighted the potential relevance of the nuclear function of IκBα as a modulator of REST activity. In cancer research, lymphomas and glioblastoma featured prominently, alongside contributions on other tumor types and new therapeutic strategies. Discussions emphasized the highly context-dependent roles of different components of the NF-κB pathway in cancer, and the substantial work still needed to translate this knowledge into effective therapies. The meeting also underscored the importance of engaging and supporting a new generation of researchers to sustain progress in the field.
Invited lectures, short talks, and poster sessions encouraged active exchange between established researchers and early-career scientists. A particular highlight was the participation of Professor Ranjan Sen, attending these international NF-κB meetings for the first time. In 1986, together with the Nobel laureate David Baltimore, he discovered the nuclear factor kappa B (NF-κB).
The congress was a great scientific and organizational success, thanks to the commitment of its participants and the support of the Hospital del Mar Research Institute Barcelona (HMRIB), the PRBB, and the sponsors, whose contributions were essential to making the meeting possible.
Special thanks go to Silvia Geeraerd, secretary of the HMRIB Cancer Program, for her outstanding commitment, enthusiasm, and dedication, and to the PhD students and postdoctoral researchers in the organizing group, whose support was instrumental in the smooth running of the congress. We also thank Aventik, a company experienced in organizing events at Hospital del Mar, for its support and professionalism.
At the close of the meeting, four cash prizes were awarded: two for the best short talks and two for the best posters. Aimilia Vareli received the first prize for best short talk, and Dina Harti, a PhD student at HMRIB, received the second. The best poster prizes went to Constanze Sixt and Hanna Norbäck.
Finally, the scientific committee unanimously agreed that the next edition of the congress will take place in 2028, organized by Dr Rudi Beyaert of Ghent University (Belgium).
See you all in Ghent in 2028!
You can download the Congress book using the button below.
Remember the Congress
































Contact
If you have any questions regarding registration, abstract submission, or general information about the NF-κB Congress 2026, please do not hesitate to contact us.
We are happy to assist you with any inquiries related to the scientific program, sponsorship opportunities, or logistical details of the event.
You can reach the Organizing Committee at:
We will do our best to respond to your message as soon as possible.
Thank you for your interest in the NF-κB Congress, Barcelona 2026 — we look forward to welcoming you to our community of researchers!
Sponsors